Page 2 - Nasdaq Blph News Today

StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Monday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance NASDAQ:BLPH opened at $0.04 on Monday. Bellerophon Therapeutics has a one year low of $0.03 and a one year high of […]

StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance NASDAQ BLPH opened at $0.03 on Friday. The stock has a market capitalization of $404,079.20, a price-to-earnings ratio of -0.04 and a […]

StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance BLPH stock opened at $0.03 on Tuesday. The company’s fifty day simple moving average is $0.22 and its 200 day simple […]

StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance Shares of BLPH opened at $0.03 on Tuesday. Bellerophon Therapeutics has a twelve month low of $0.03 and […]

StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance BLPH opened at $0.04 on Monday. The stock has a market capitalization of $433,431.20, a P/E ratio of -0.03 and a beta […]

Stock analysts at StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a report released on Monday. The firm set a “hold” rating on the biotechnology company’s stock. Bellerophon Therapeutics Trading Up 2.6 % BLPH stock opened at $0.04 on Monday. The firm has a market cap of $476,970.00, a […]

StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance BLPH opened at $0.04 on Friday. The company has a market capitalization of $458,737.50, a PE ratio of -0.03 […]

StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Trading Up 5.0 % BLPH opened at $0.38 on Thursday. The stock’s 50-day moving average price is $0.42 and its 200 day […]

StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note released on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Several other research analysts also recently issued reports on BLPH. HC Wainwright cut their price objective on Bellerophon Therapeutics from $30.00 to $2.00 in […]

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 197,500 shares, an increase of 59.8% from the August 31st total of 123,600 shares. Based on an average trading volume of 193,800 shares, […]